Logo image
Management of Challenging Radioiodine Treatment Protocols: A Case Series and Review of the Literature
Journal article   Open access   Peer reviewed

Management of Challenging Radioiodine Treatment Protocols: A Case Series and Review of the Literature

Joseph Waller, Courtney A. Lawhn-Heath, Cathleen Edmonds, Chloee Wendorf, Brandon Holmes, Michael White, Miguel Hernandez Pampaloni, Chienying Liu and Robert R. Flavell
Journal of nuclear medicine technology, v 49(2), pp 180-185
01 Jun 2021
PMID: 33219159
url
https://doi.org/10.2967/jnmt.120.255307View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging Science & Technology
Radioactive iodine (RAI) therapy with I-131 is the standard of care for treatment in many patients with differentiated thyroid cancer. Because I-131 is typically administered as a pill, and much of its radioactivity is excreted via the urine, there can be challenges in patients who cannot swallow pills, absorb iodine via the gastrointestinal tract, or eliminate RAI via the urine (i.e., dialysis patients and patients with renal failure). In this article, we present 3 cases in which the standard I-131 treatment protocol for thyroid cancer could not be used because of these challenges, and we discuss the strategies used to overcome them. Provider collaboration and treatment customization are critical in overcoming patient-specific challenges.

Metrics

7 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Radiology, Nuclear Medicine & Medical Imaging
Logo image